Directional Deep Brain Stimulation for Parkinson's Disease: Results of an International Crossover Study With Randomized, Double-Blind Primary Endpoint
Neuromodulation Technology at the Neural Interface2021Vol. 25(6), pp. 817–828
Citations Over TimeTop 10% of 2021 papers
Alfons Schnitzler, Pablo Mir, Matthew Brodsky, L. Verhagen, Sergiu Groppa, Ramiro Álvarez, Andrew Evans, Marta Blázquez Estrada, Sean J. Nagel, Julie G. Pilitsis, Monika Pötter‐Nerger, Winona Tse, Leonardo Almeida, Nestor Tomycz, Joohi Jimenez‐Shahed, Witold Libionka, Fátima Carrillo, Christian J. Hartmann, Stefan Jun Groiss, Martin Gläser, Florence Defresne, Edward Karst, Binith Cheeran, Jan Vesper, Alfons Schnitzler, Jan Vesper, Pablo Mir, Leonardo Verhagen, Nestor Tomcyz, Christian J. Hartmann, Sergiu Groppa, Ramiro Álvarez, Julie G. Pilitsis, Monika Pötter‐Nerger, Stefan Jun Groiss, Matthew Brodsky
Abstract
Directional stimulation yielded a wider TW compared to omnidirectional stimulation and was preferred by blinded subjects and clinicians.
Related Papers
- → Deep brain stimulation of the subthalamic nucleus improves sense of well‐being in parkinson's disease(2012)20 cited
- → Two cases of unexpected long-term improvement of Parkinson's disease after subthalamic nucleus deep brain stimulation removal(2011)2 cited
- → Various targeting methods for subthalamic nucleus in deep brain stimulation(2019)1 cited
- → Post-Mortem Analysis of Parkinson’s Disease Brains After 11 and 12 Years of Deep Brain Stimulation of the Subthalamic Nucleus(2022)1 cited
- → PO061 / #228 LONG-TERM OUTCOME OF SUBTHALAMIC NUCLEUS DEEP BRAIN STIMULATION FOR PARKINSON’S DISEASE: 10 YEARS AND BEYOND(2022)